IL134042A0 - Modified dorsal tissue affecting factor and compositions - Google Patents

Modified dorsal tissue affecting factor and compositions

Info

Publication number
IL134042A0
IL134042A0 IL13404298A IL13404298A IL134042A0 IL 134042 A0 IL134042 A0 IL 134042A0 IL 13404298 A IL13404298 A IL 13404298A IL 13404298 A IL13404298 A IL 13404298A IL 134042 A0 IL134042 A0 IL 134042A0
Authority
IL
Israel
Prior art keywords
compositions
affecting factor
tissue affecting
dorsal tissue
modified
Prior art date
Application number
IL13404298A
Other languages
English (en)
Original Assignee
Regeneron Pharma
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma, Univ California filed Critical Regeneron Pharma
Publication of IL134042A0 publication Critical patent/IL134042A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13404298A 1997-07-17 1998-07-17 Modified dorsal tissue affecting factor and compositions IL134042A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/897,236 US6075007A (en) 1997-07-17 1997-07-17 Modified noggin polypeptide and compositions
PCT/US1998/014603 WO1999003996A1 (en) 1997-07-17 1998-07-17 Modified dorsal tissue affecting factor and compositions

Publications (1)

Publication Number Publication Date
IL134042A0 true IL134042A0 (en) 2001-04-30

Family

ID=25407592

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13404298A IL134042A0 (en) 1997-07-17 1998-07-17 Modified dorsal tissue affecting factor and compositions
IL134042A IL134042A (en) 1997-07-17 2000-01-13 Modified dorsal tissue affecting factor and compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL134042A IL134042A (en) 1997-07-17 2000-01-13 Modified dorsal tissue affecting factor and compositions

Country Status (10)

Country Link
US (3) US6075007A (de)
EP (1) EP1003860B1 (de)
JP (1) JP4181300B2 (de)
AT (1) ATE252639T1 (de)
AU (1) AU735851B2 (de)
CA (1) CA2296769C (de)
DE (1) DE69819167T2 (de)
HK (1) HK1026229A1 (de)
IL (2) IL134042A0 (de)
WO (1) WO1999003996A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2339968A1 (en) 1998-08-20 2000-03-02 Regeneron Pharmaceuticals, Inc. Dcr5, a bmp-binding protein, and applications thereof
DK2261335T3 (en) 1998-11-27 2017-09-18 Ucb Pharma Sa Compositions and Methods for Increasing Bone Mineralization
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
US7303746B2 (en) 1999-06-08 2007-12-04 Regeneron Pharmaceuticals, Inc. Methods of treating eye disorders with modified chimeric polypeptides
US7306799B2 (en) 1999-06-08 2007-12-11 Regeneron Pharmaceuticals, Inc. Use of VEGF inhibitors for treatment of eye disorders
US7070959B1 (en) 1999-06-08 2006-07-04 Regeneron Pharmaceuticals, Inc. Modified chimeric polypeptides with improved pharmacokinetic properties
EP1357828A2 (de) * 2001-01-12 2003-11-05 University of Medicine and Dentistry of New Jersey Knochenmorphogenetisches protein-2 bei der behandlung und diagnose von krebs
WO2002087632A1 (en) * 2001-05-02 2002-11-07 Metaprobe, Inc. High throughput screening methods using magnetic resonance imaging agents
US20030134790A1 (en) * 2002-01-11 2003-07-17 University Of Medicine And Dentistry Of New Jersey Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer
WO2003070189A2 (en) * 2002-02-15 2003-08-28 Cornell Research Foundation, Inc. Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
US7799523B2 (en) 2002-04-03 2010-09-21 Celltech R & D, Inc. Association of polymorphisms in the SOST gene region with bone mineral density
ATE540977T1 (de) * 2003-03-14 2012-01-15 Ucb Mfg Inc Komplex von sclerostin mit noggin oder chordin, und modulatoren der bildung dieses komplexes
EP1636270B1 (de) 2003-06-16 2016-07-20 UCB Pharma S.A. Spezifische antikörper für sclerostin und verfahren zur erhöhung der knochenmineralisierung
DK2341147T3 (da) * 2004-07-09 2019-11-11 Viacyte Inc Præprimitive stribe- og mesendodermceller
US7592429B2 (en) 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
US8003108B2 (en) 2005-05-03 2011-08-23 Amgen Inc. Sclerostin epitopes
WO2007028212A1 (en) * 2005-09-08 2007-03-15 Apollo Life Sciences Limited Noggin and chimeric molecules thereof
CL2008002775A1 (es) 2007-09-17 2008-11-07 Amgen Inc Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
KR101163171B1 (ko) * 2009-01-20 2012-07-19 (주)케어젠 노긴?유래 펩타이드 및 그의 용도
ES2849181T3 (es) * 2009-04-22 2021-08-16 Viacyte Inc Composiciones celulares derivadas de células reprogramadas desdiferenciadas
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
KR101861867B1 (ko) 2010-05-14 2018-05-29 암젠 인크 고농도의 항체 제제
EP2662385A4 (de) * 2011-01-07 2015-11-11 Chugai Pharmaceutical Co Ltd Verfahren zur verbesserung der physikalischen eigenschaften von antikörpern
CN103649118A (zh) 2011-03-01 2014-03-19 安进公司 双特异性结合剂
CR20160147A (es) 2011-03-25 2016-08-03 Amgen Inc Formulaciones de anticuerpos
JO3283B1 (ar) 2011-04-26 2018-09-16 Sanofi Sa تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
MX355816B (es) 2011-08-04 2018-05-02 Amgen Inc Metodo para tratar los defectos de espacio oseo.
MX354270B (es) 2011-12-28 2018-02-21 Amgen Inc Uso de un anticuerpo antiesclerostina en el tratamiento de la pérdida ósea alveolar. .
CN104619342A (zh) 2012-07-05 2015-05-13 Ucb医药有限公司 骨疾病的治疗
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US8859286B2 (en) 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
US9914769B2 (en) 2014-07-15 2018-03-13 Kymab Limited Precision medicine for cholesterol treatment
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
LT3170005T (lt) 2014-07-18 2019-07-10 Sanofi Paciento, įtariamo, kad serga vėžiu, gydymo afliberceptu rezultato prognozavimo būdas
MA41142A (fr) 2014-12-12 2017-10-17 Amgen Inc Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement
GB201604124D0 (en) 2016-03-10 2016-04-27 Ucb Biopharma Sprl Pharmaceutical formulation
WO2018083248A1 (en) 2016-11-03 2018-05-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
CA3093457A1 (en) 2018-03-30 2019-10-03 Amgen Inc. C-terminal antibody variants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256568A (en) 1990-02-12 1993-10-26 Regeneron Phamaceuticals, Inc. Vectors and transformed most cells for recombinant protein production with reduced expression of selectable markers
JPH06501617A (ja) 1990-09-25 1994-02-24 ジェネンテク，インコーポレイテッド 新規な神経栄養因子
JP3431153B2 (ja) * 1992-09-03 2003-07-28 リジエネロン・フアーマシユーテイカルズ・インコーポレーテツド 背側組織作用因子及び組成物
ES2149823T3 (es) * 1992-09-03 2000-11-16 Univ California Factor y composiciones que afectan al tejido dorsal.

Also Published As

Publication number Publication date
DE69819167D1 (de) 2003-11-27
AU735851B2 (en) 2001-07-19
JP2001510044A (ja) 2001-07-31
CA2296769A1 (en) 1999-01-28
US20030129703A1 (en) 2003-07-10
IL134042A (en) 2006-12-10
DE69819167T2 (de) 2004-07-22
ATE252639T1 (de) 2003-11-15
EP1003860B1 (de) 2003-10-22
HK1026229A1 (en) 2000-12-08
US6500640B1 (en) 2002-12-31
JP4181300B2 (ja) 2008-11-12
CA2296769C (en) 2008-01-15
US6075007A (en) 2000-06-13
WO1999003996A1 (en) 1999-01-28
EP1003860A1 (de) 2000-05-31
AU8570898A (en) 1999-02-10

Similar Documents

Publication Publication Date Title
IL134042A0 (en) Modified dorsal tissue affecting factor and compositions
ZA983148B (en) Modified TNFÓ, DNA encoding such modified TNFÓ and vacines comprising said TNFÓ and DNA.
HK1022701A1 (en) Exendin analogues, processes for their preparationand medicaments containing them exendin.
HK1047887A1 (en) Use of thiazolidin- or pyrrolidin-derivatives of aminoacids as antihyperglycemic agents.
EP1019028A4 (de) Chlamydiaprotein, gensequenz und deren verwendungen
ZA975211B (en) Compositions and methods for administering borrelia DNA.
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
GR3024597T3 (en) 7-deazapurine modified oligonucleotides
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
WO1994005791A3 (en) Dorsal tissue affecting factor and compositions
ZA977513B (en) Skin tanning compositions and method.
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
WO1997020933A3 (en) Mutational variants of mammalian ob gene proteins
EP1123414A4 (de) Antisense modulation der expression von integrin alpha 4
DK1071767T3 (da) Gen, der koder for heliomicin, og anvendelse heraf
ZA971272B (en) Gene expression.
HUP0104825A3 (en) Genes and proteins, and their use
HK1048318A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors.
ZA982023B (en) Personal Gaming System.
EP1012297A4 (de) Polyphenoloxidase gene von banane, tabak und ananas
PE20399A1 (es) Muteina ob
AP2006003504A0 (en) Outer surface proteins, their genes, and their use.
EP0970192A4 (de) Nukleinsäure, die für das algu protein von m. tuberculosis kodiert.
IT242987Y1 (it) Guarnitura per mobili.
HK1043479A1 (zh) 生物學組合物及其成分和用途

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed